Sponsors (2)
Official title: To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
Introduced July 14, 2026 by Nicholas A. Langworthy · Last progress July 14, 2026